Shiori Nakagawa

Kanazawa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Interstitial palladin is associated with tubulointerstitial chronicity and adverse outcomes in patients with lupus nephritis.

Interstitial palladin is associated with tubulointerstitial chronicity and adverse outcomes in patients with lupus nephritis.

Journal: Lupus

Published: August 20, 2026

Lower-dose glucocorticoid therapy achieves comparable outcomes in Japanese patients with lupus nephritis.

Lower-dose glucocorticoid therapy achieves comparable outcomes in Japanese patients with lupus nephritis.

Journal: Lupus

Published: May 06, 2026

Circulating kidney injury molecule-1 as a prognostic biomarker for long-term renal outcomes in lupus nephritis: a retrospective cohort study.

Circulating kidney injury molecule-1 as a prognostic biomarker for long-term renal outcomes in lupus nephritis: a retrospective cohort study.

Journal: Lupus science & medicine

Published: March 24, 2026

Early Renal Remission Is Associated with Increased Likelihood of Subsequent Remission in Lupus Nephritis: Single-Centre Observational Study in Australia.

Early Renal Remission Is Associated with Increased Likelihood of Subsequent Remission in Lupus Nephritis: Single-Centre Observational Study in Australia.

Journal: International journal of molecular sciences

Published: July 25, 2025

CD45 + C1q + CCR8+ Cells as Emerging Indicators of Kidney Disease Severity and Progression Risk.

CD45 + C1q + CCR8+ Cells as Emerging Indicators of Kidney Disease Severity and Progression Risk.

Journal: Nephrology (Carlton, Vic.)

Published: June 23, 2025

Effects of risperidone on amino acid metabolism, glucose, and kidney function in healthy adults: A pilot randomized controlled trial.

Effects of risperidone on amino acid metabolism, glucose, and kidney function in healthy adults: A pilot randomized controlled trial.

Journal: PloS one

Published: May 20, 2025

d-Alanine Supplementation for Chronic Kidney Disease: A Study Protocol for a Pilot Randomized Controlled Trial.

d-Alanine Supplementation for Chronic Kidney Disease: A Study Protocol for a Pilot Randomized Controlled Trial.

Journal: Chemistry & biodiversity

Published: March 16, 2025

Fibroblast-specific palladin drives kidney fibrosis via MRTF-SRF signaling.

Fibroblast-specific palladin drives kidney fibrosis via MRTF-SRF signaling.

Journal: The Journal of pathology

Published: March 11, 2025

Serum matrix metalloproteinase-9 as a predictor of recurrence in idiopathic nephrotic syndrome.

Serum matrix metalloproteinase-9 as a predictor of recurrence in idiopathic nephrotic syndrome.

Journal: Clinical and experimental nephrology

Published: February 17, 2025

Impact of glucocorticoid tapering speed on renal outcomes in proliferative lupus nephritis: a multicentre retrospective study.

Impact of glucocorticoid tapering speed on renal outcomes in proliferative lupus nephritis: a multicentre retrospective study.

Journal: Rheumatology (Oxford, England)

Published: January 30, 2025

Effects of sake lees intake on fecal uremic toxins, plasma D-alanine, constipation, and gut microbiome in healthy adults: A single-arm clinical trial.

Effects of sake lees intake on fecal uremic toxins, plasma D-alanine, constipation, and gut microbiome in healthy adults: A single-arm clinical trial.

Journal: PloS one

Published: December 14, 2024

Correction: Kidney lesions and risk of cardiovascular events in biopsy-proven diabetic kidney disease with type 2 diabetes.

Correction: Kidney lesions and risk of cardiovascular events in biopsy-proven diabetic kidney disease with type 2 diabetes.

Journal: Clinical and experimental nephrology

Published: December 03, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026